Selexipag is a medication that belongs to a class of drugs known as prostacyclin receptor agonists. It is used in the treatment of pulmonary arterial hypertension (PAH), a condition characterized by high blood pressure in the arteries of the lungs. Selexipag works by activating the prostacyclin receptor, which helps to dilate the blood vessels in the lungs and improve blood flow.

Patients with PAH often experience symptoms such as shortness of breath, fatigue, and chest pain, which can significantly impact their quality of life. Selexipag has been shown to help improve exercise capacity and reduce symptoms in patients with PAH. It is typically taken orally, either with or without food, as directed by a healthcare provider.

As with any medication, there are potential side effects associated with Selexipag. These can include headache, diarrhea, nausea, and jaw pain. It is important for patients to discuss any concerns or side effects with their healthcare provider to determine the best course of action.

It is also important for patients taking Selexipag to follow their healthcare provider’s instructions closely and attend regular follow-up appointments to monitor their progress. This medication may interact with other drugs, so it is important to inform your healthcare provider of all medications you are taking.

Overall, Selexipag can be an effective treatment option for patients with PAH, helping to improve symptoms and quality of life. If you have been prescribed Selexipag, be sure to take it as directed and communicate openly with your healthcare provider about any concerns or side effects you may experience.